Evidence-Based Clinical Practice Guidelines on Regenerative Medicine Treatments in Pain Management
In brief
These evidence-based guidelines from the American Society of Pain and Neuroscience (ASPN) were developed by an expert panel using a consensus process on injectable biologics for chronic pain. The panel concludes that, in carefully selected patients with certain conditions, these treatments may improve pain and function, while calling for better-quality trials and standardised preparation.
Read the original paper (opens in a new tab)
Citation, as listed in the BMAC guidelines
4. Evidence-Based Clinical Practice Guidelines on Regenerative Medicine Treatments in Pain Management. PMC. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11402349/
A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.
More from the BMAC guidelines
- Exploring Bias Patterns in Systematic Reviews and Meta-Analyses of Bone Marrow Aspirate Concentrate2026
- Intra-articular Injections for Shoulder Arthritis in Adults: A Systematic Review2025
- Evaluating Clinical Outcomes of Recombinant Human Bone Morphogenetic Protein-2 with ECM and BMAC for Ankle Osteochondral Lesions with Subchondral Damage2025
- Centrifuge-Free Bone Marrow Aspirate Harvest for Orthopaedic Applications2025

